Marc Fouassier

1.2k total citations
49 papers, 601 citations indexed

About

Marc Fouassier is a scholar working on Hematology, Surgery and Genetics. According to data from OpenAlex, Marc Fouassier has authored 49 papers receiving a total of 601 indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Hematology, 9 papers in Surgery and 8 papers in Genetics. Recurrent topics in Marc Fouassier's work include Platelet Disorders and Treatments (29 papers), Blood Coagulation and Thrombosis Mechanisms (11 papers) and Hemophilia Treatment and Research (11 papers). Marc Fouassier is often cited by papers focused on Platelet Disorders and Treatments (29 papers), Blood Coagulation and Thrombosis Mechanisms (11 papers) and Hemophilia Treatment and Research (11 papers). Marc Fouassier collaborates with scholars based in France, United Kingdom and United States. Marc Fouassier's co-authors include Catherine Ternisien, Marc Trossaërt, Yves Gruel, Pierre Guéret, Marianne Sigaud, S. Régina, Claire Pouplard, Dominique Heymann, Laurence Duplomb and Pierre Boisseau and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Marc Fouassier

47 papers receiving 586 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marc Fouassier France 13 378 177 114 98 88 49 601
Nathalie Hézard France 15 315 0.8× 126 0.7× 155 1.4× 23 0.2× 166 1.9× 37 545
Lori Dewar Canada 11 222 0.6× 181 1.0× 194 1.7× 93 0.9× 126 1.4× 15 477
Jeanne M. Osborne United States 8 224 0.6× 178 1.0× 65 0.6× 70 0.7× 36 0.4× 9 531
Sonja Werwitzke Germany 13 471 1.2× 202 1.1× 39 0.3× 38 0.4× 36 0.4× 38 752
I. Birgitta Sundell United States 11 217 0.6× 113 0.6× 71 0.6× 17 0.2× 152 1.7× 25 657
Naveen Manchanda United States 9 175 0.5× 337 1.9× 35 0.3× 27 0.3× 27 0.3× 16 751
Asher Winder Israel 11 228 0.6× 65 0.4× 36 0.3× 14 0.1× 59 0.7× 21 551
William B. Scharfman United States 13 220 0.6× 197 1.1× 109 1.0× 87 0.9× 46 0.5× 23 462
Ilya Kirgner Israel 10 119 0.3× 47 0.3× 60 0.5× 21 0.2× 29 0.3× 31 285
Rakhee Kar India 12 211 0.6× 70 0.4× 10 0.1× 44 0.4× 33 0.4× 105 532

Countries citing papers authored by Marc Fouassier

Since Specialization
Citations

This map shows the geographic impact of Marc Fouassier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc Fouassier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc Fouassier more than expected).

Fields of papers citing papers by Marc Fouassier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marc Fouassier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc Fouassier. The network helps show where Marc Fouassier may publish in the future.

Co-authorship network of co-authors of Marc Fouassier

This figure shows the co-authorship network connecting the top 25 collaborators of Marc Fouassier. A scholar is included among the top collaborators of Marc Fouassier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marc Fouassier. Marc Fouassier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sigaud, Marianne, et al.. (2024). Bleeding management in type 3 von Willebrand disease with anti‐von Willebrand factor inhibitor: A literature review and case report. SHILAP Revista de lepidopterología. 5(5). 964–970. 3 indexed citations
2.
Desprez, Dominique, Laurent Sattler, Catherine Ternisien, et al.. (2024). Efficacy and safety of a recombinant von Willebrand factor treatment in acquired von Willebrand syndrome in case of bleeding and surgical procedures. Haemophilia. 30(6). 1341–1347. 1 indexed citations
3.
Guillet, Benoît, B. Wibaut, Annie Harroche, et al.. (2023). A French Real-World Evidence Study Evaluating the Efficacy, Safety, and Pharmacokinetic Parameters of rVIII-SingleChain in Patients with Hemophilia A Receiving Prophylaxis. Thrombosis and Haemostasis. 123(5). 490–500. 2 indexed citations
4.
Debord, Camille, Marion Eveillard, Marc Trossaërt, et al.. (2023). Prothrombin consumption as an indicator of hemorrhagic phenotype in mild platelet function disorders. European Journal Of Haematology. 111(5). 787–795.
5.
Beurrier, Philippe, et al.. (2023). Efficacy and safety of turoctocog alfa in patients with hemophilia A requiring surgical procedures: A multicentre retrospective study. Transfusion. 63(12). 2321–2327. 1 indexed citations
6.
7.
Sigaud, Marianne, Catherine Ternisien, Marc Fouassier, et al.. (2021). Prostate interventions in patients with mild haemophilia: Safe and feasible. Haemophilia. 27(6). e659–e666. 3 indexed citations
8.
Rugeri, Lucia, Marc Fouassier, Anne Lienhart, et al.. (2020). Management of previously untreated patients with severe haemophilia A preferentially treated with recombinant factor VIII products: Two French centres' real‐life experience. Haemophilia. 26(6). e349–e352. 1 indexed citations
9.
Fournier, Élise, Camille Debord, Valérie Soenen, et al.. (2020). Baseline dysmegakaryopoiesis in inherited thrombocytopenia/platelet disorder with predisposition to haematological malignancies. British Journal of Haematology. 189(4). e119–e122. 8 indexed citations
10.
Boissier, Elodie, Thomas Sénage, Isabelle Gouin‐Thibault, et al.. (2020). Heparin Anti-Xa Activity, a Readily Available Unique Test to Quantify Apixaban, Rivaroxaban, Fondaparinux, and Danaparoid Levels. Anesthesia & Analgesia. 132(3). 707–716. 19 indexed citations
11.
Trossaërt, Marc, J. Graveleau, Marianne Sigaud, et al.. (2019). The factor VIII:C/VWF:Ag ratio as a useful tool to predict relapse in patients with acquired haemophilia A: A retrospective cohort study. Haemophilia. 25(3). 527–534. 6 indexed citations
12.
Soueidan, Assem, et al.. (2018). Multidisciplinary Clinical Management of a Localized Aggressive Periodontitis diagnosed in a Child with Glanzmann\'s Thrombasthenia. International Journal of Clinical Pediatric Dentistry. 11(4). 344–348. 4 indexed citations
13.
Graveleau, J., Marc Fouassier, Catherine Ternisien, et al.. (2014). Management of bleeding in severe factor V deficiency with a factor V inhibitor. Vox Sanguinis. 107(1). 97–99. 9 indexed citations
14.
Dargaud, Yesim, Marc Fouassier, Sophie Ducastelle, et al.. (2014). The Challenge of Myeloma-Related Thromboembolic Disease: Can Thrombin Generation Assay May Detect Disease-Related Hypercoagulability?. Blood. 124(21). 2037–2037. 1 indexed citations
15.
Trossaërt, Marc, Catherine Ternisien, Jenny Goudemand, et al.. (2010). Evaluation of an Automated von Willebrand Factor Activity Assay in von Willebrand Disease. Clinical and Applied Thrombosis/Hemostasis. 17(6). E25–E29. 21 indexed citations
16.
Trossaërt, Marc, Pierre Boisseau, Agnès Quéméner, et al.. (2010). Prevalence, biological phenotype and genotype in moderate/mild hemophilia A with discrepancy between one‐stage and chromogenic factor VIII activity. Journal of Thrombosis and Haemostasis. 9(3). 524–530. 34 indexed citations
17.
Fouassier, Marc, et al.. (2009). Increase in proinflammatory cytokines in peripheral blood without haemostatic changes after LPS inhalation. Thrombosis Research. 124(5). 584–587. 3 indexed citations
18.
Picard, Véronique, Ulrike Nowak‐Göttl, Christine Biron‐Andréani, et al.. (2006). Molecular bases of antithrombin deficiency: twenty-two novel mutations in the antithrombin gene. Human Mutation. 27(6). 600–600. 44 indexed citations
19.
Boiret, Nathalie, Justyna Kanold, Marc Fouassier, et al.. (2000). CFU-Mk Content of Immunoselected CD34 + Peripheral Blood Progenitor Cells, Evaluated with an Adapted Serum-Free Methylcellulose Assay, Is Predictive of Platelet Lineage Reconstitution in Children with Solid Tumors. Journal of Hematotherapy & Stem Cell Research. 9(4). 525–534. 10 indexed citations
20.
Bay, J.-O., Marc Fouassier, David M. Beal, et al.. (1997). Autoimmune thrombocytopenia after six cycles of fludarabine phosphate in a patient with chronic lymphotic leukemia. PubMed. 39(4). 209–212. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nathalie Hézard Breakdown of academic impact, for papers by Lori Dewar Breakdown of academic impact, for papers by Jeanne M. Osborne Breakdown of academic impact, for papers by Sonja Werwitzke Breakdown of academic impact, for papers by I. Birgitta Sundell Breakdown of academic impact, for papers by Naveen Manchanda Breakdown of academic impact, for papers by Asher Winder Breakdown of academic impact, for papers by William B. Scharfman Breakdown of academic impact, for papers by Ilya Kirgner Breakdown of academic impact, for papers by Rakhee Kar
Rankless by CCL
2026